Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 26  •  04:00PM ET
0.7900
Dollar change
-0.0100
Percentage change
-1.25
%
Index
-
P/E
-
EPS (ttm)
-0.66
Insider Own
20.25%
Shs Outstand
51.36M
Perf Week
-6.95%
Market Cap
40.58M
Forward P/E
-
EPS next Y
-0.41
Insider Trans
0.00%
Shs Float
40.96M
Perf Month
-62.02%
Enterprise Value
103.31M
PEG
-
EPS next Q
-0.19
Inst Own
39.02%
Perf Quarter
-77.75%
Income
-33.18M
P/S
0.37
EPS this Y
7.87%
Inst Trans
1.16%
Perf Half Y
-75.69%
Sales
110.97M
P/B
-
EPS next Y
34.10%
ROA
-19.77%
Perf YTD
-77.87%
Book/sh
-0.39
P/C
0.94
EPS next 5Y
29.98%
ROE
-2440.41%
52W High
5.33 -85.18%
Perf Year
-61.27%
Cash/sh
0.84
P/FCF
-
EPS past 3/5Y
37.71% 27.91%
ROIC
-39.54%
52W Low
0.68 16.18%
Perf 3Y
-78.59%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
42.79% 42.48%
Gross Margin
59.12%
Volatility
8.02% 9.04%
Perf 5Y
-
Dividend TTM
-
EV/Sales
0.93
EPS Y/Y TTM
42.75%
Oper. Margin
-16.87%
ATR (14)
0.16
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
1.46
Sales Y/Y TTM
17.42%
Profit Margin
-29.90%
RSI (14)
15.57
Dividend Gr. 3/5Y
- -
Current Ratio
1.63
EPS Q/Q
7.20%
SMA20
-48.79%
Beta
0.57
Payout
-
Debt/Eq
-
Sales Q/Q
12.74%
SMA50
-62.32%
Rel Volume
2.84
Prev Close
0.80
Employees
364
LT Debt/Eq
-
SMA200
-76.16%
Avg Volume
503.19K
Price
0.79
IPO
Nov 04, 2021
Option/Short
No / Yes
Trades
Volume
1,343,984
Change
-1.25%
Date Action Analyst Rating Change Price Target Change
May-14-26Downgrade William Blair Outperform → Mkt Perform
Jul-17-25Initiated Craig Hallum Buy $8
Oct-31-24Initiated Lake Street Buy $7
May-31-23Initiated TD Cowen Outperform $7
Jul-18-22Resumed Oppenheimer Outperform $18
May-14-26 01:02AM
May-13-26 04:00PM
Apr-30-26 04:00PM
Mar-16-26 04:00PM
Feb-27-26 08:30AM
12:07AM Loading…
12:07AM
Feb-26-26 05:48PM
04:00PM
Feb-12-26 05:00PM
Jan-12-26 08:00AM
Jan-07-26 08:21AM
Jan-06-26 08:00AM
Nov-13-25 12:00AM
Nov-12-25 04:01PM
Nov-03-25 04:01PM
08:50AM Loading…
Oct-29-25 08:50AM
Sep-21-25 09:16AM
Sep-15-25 05:29PM
Aug-06-25 03:27AM
Aug-05-25 08:00PM
04:30PM
04:01PM
Jul-03-25 01:00PM
May-15-25 03:15AM
May-14-25 05:10PM
04:00PM
May-13-25 09:45AM
May-08-25 05:50PM
May-07-25 05:25PM
Apr-30-25 04:00PM
09:35AM Loading…
Mar-06-25 09:35AM
Feb-27-25 02:21AM
Feb-26-25 05:10PM
04:00PM
Feb-12-25 04:00PM
Jan-13-25 05:00AM
Nov-25-24 08:30AM
Nov-07-24 02:29AM
Nov-06-24 04:00PM
Nov-05-24 08:08AM
Oct-28-24 05:01PM
Oct-14-24 08:00AM
Sep-25-24 09:31PM
04:05PM
Aug-21-24 08:53PM
04:00PM
Aug-12-24 04:00PM
Jul-08-24 08:00AM
08:00AM
May-15-24 04:00PM
May-06-24 08:52AM
May-01-24 01:53PM
07:45AM
Mar-28-24 01:30PM
Mar-12-24 04:00PM
Mar-07-24 10:42AM
Mar-06-24 04:00PM
Feb-21-24 05:00PM
Feb-16-24 08:45AM
Jan-08-24 04:00PM
Dec-18-23 01:00AM
Nov-27-23 01:00AM
Nov-14-23 04:00PM
Nov-13-23 04:00PM
Nov-08-23 04:00PM
Nov-06-23 01:00AM
Oct-25-23 04:00PM
Oct-20-23 04:00PM
Oct-09-23 04:00PM
Oct-02-23 04:04PM
Sep-26-23 04:46PM
Aug-23-23 04:00PM
Aug-10-23 04:00PM
Aug-09-23 04:00PM
Aug-03-23 07:25PM
Jun-30-23 04:00PM
Jun-05-23 05:30PM
May-25-23 04:30PM
May-23-23 04:00PM
May-15-23 04:00PM
May-01-23 04:00PM
Apr-25-23 04:00PM
Apr-19-23 04:00PM
Apr-07-23 04:30PM
Mar-13-23 02:00AM
Mar-08-23 05:00PM
04:00PM
Mar-06-23 05:34PM
Mar-03-23 04:30PM
Feb-28-23 04:30PM
Feb-22-23 04:30PM
Feb-21-23 04:30PM
Feb-15-23 04:30PM
Feb-13-23 04:00PM
Feb-03-23 08:00AM
Feb-01-23 04:00PM
Jan-20-23 01:00AM
Jan-09-23 04:00PM
Dec-19-22 05:00PM
Nov-29-22 04:06PM
MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, Europe and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.
CEO & Executive DirectorMr. Michael K. McGarrity
Interim Chief Financial OfficerMr. Ron Kalfus CPA
LLMMr. Joseph Sollee J.D.
Chief Commercial OfficerMr. John A. Bellano
Vice President of Finance & AccountingMr. Scott McMahan